Germany | Bayern

Zurück zur Suche

Internationale Partnersuche

Forschung & Entwicklung Anfrage

H2020 SC1-BHC-07-2019: Clinical and research related partners sought for a project consortium

Country of Origin: Germany
Reference Number: RDDE20181120001
Publication Date: 10 December 2018

Summary

A German research institute is preparing a proposal for the H2020 SC1-BHC-07-2019 call. Focus is a biomaterial platform that can be customized for various, engineered tissue types. The aim is to overcome current state of the art constrains in cell sheet engineering. The institute will take the lead and is looking for Health Technology partners and/or for clinical partners (tissue engineering) to join the consortium and to conclude a research cooperation agreement.

Description

A Research institute from Germany with a strong expertise and history in the field of biomaterials plans to submit a proposal within the H2020 SC1-BHC-07-2019 call. The institute will overtakte the role as lead partner. Now they are looking for project partners to join the consortium. 

The objective is to develop a biomaterial that is not only able to ensure a healthy cell culturing process but also to extract the engineered tissue without causing any damage by a controlled degradation process.

As a proof of concept, the usefulness of this technique has been demonstrated by creating corneal endothelial lamellae (artificial Descemet membrane endothelial keratoplasty (DMEK) tissue) ex vivo. The project proposal aims to apply this technology to different tissue types other than cornea.

The German Research institute is now looking for cooperation with Health Technology partners and clinical partners, who want to support the idea and are interested in a 3-5 years partnership- 156-260 weeks).

In concrete, they are looking for following partners:
- Partners from clinical research areas (tissue engineering), who would be willing to test and apply the biotechnology platform
- Health Technology partners to support the regulatory issues of the project

The optimal partner should provide complementary expertise in the outlined field, potentially in testing either pharmaceutical or biomedical applicability of the compounds developed. Expertise in EU-projects and expertise of respective content is prerequisite.

Expressions of Interest are welcome until 10.01.2019
Call deadline: 16th April 2019

Advantages and Innovations

The project will aim to deliver biotechnology solutions which are suitable for effective regenerative medicine applications as well as to overcome current constraints of the state of the art. 

The ultimate goal is to achieve synergies through collaboration between industry and science to advance regenerative medicine towards clinical applications.

Expertise sought

Partners from clinical research areas with expertise in tissue engineering and health technology partners are sought.

Stage Of Development

Proposal under development

Requested partner

The German research institute will act as leading partner. They are looking for project partners from clinical research areas (all types of cell sheet engineering, especially in the field of cardiovascular engineering), clinics or related research institutes, who would use the biomaterial for tissue engineering research.

Roles and skills:
- Research on culturing of cell sheets
- Project partner in the H2020-consortium
- Test and apply the biotechnology platform
- Willing to conduct or participate in clinical studies

Health Technology partners:
- Consultancies/companies with knowledge about clinical studies
- Consultancies/companies with knowledge in field of ATMP (Advanced Therapy Medicinal Products) and CE-Certification
- Ethical researcher
- Partners, who support the regulatory issues of the project

Cooperation offer ist closed for requests